{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:02:33Z","timestamp":1793714553804,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T00:00:00Z","timestamp":1397347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1038\/nm.3516","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T23:22:16Z","timestamp":1397431336000},"page":"518-523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":269,"title":["Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2"],"prefix":"10.1038","volume":"20","author":[{"given":"Alastair J","family":"O'Brien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N","family":"Fullerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A","family":"Massey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Auld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Newson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effie","family":"Karra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Winstanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Alazawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Garcia-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Cordoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nicolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek W","family":"Gilroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,13]]},"reference":[{"key":"BFnm3516_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.cld.2008.07.007","volume":"12","author":"YS Lim","year":"2008","unstructured":"Lim, Y.S. & Kim, W.R. The global impact of hepatic fibrosis and end-stage liver disease. Clin. Liver Dis. 12, 733\u2013746 (2008).","journal-title":"Clin. Liver Dis."},{"key":"BFnm3516_CR2","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1172\/JCI109391","volume":"63","author":"J Fierer","year":"1979","unstructured":"Fierer, J. & Finley, F. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver. J. Clin. Invest. 63, 912\u2013921 (1979).","journal-title":"J. Clin. Invest."},{"key":"BFnm3516_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/jhep.2002.30082","volume":"35","author":"J Fern\u00e1ndez","year":"2002","unstructured":"Fern\u00e1ndez, J. et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35, 140\u2013148 (2002).","journal-title":"Hepatology"},{"key":"BFnm3516_CR4","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau, R. et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 144, 1426\u20131437 (2013).","journal-title":"Gastroenterology"},{"key":"BFnm3516_CR5","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/hep.25532","volume":"55","author":"J Fern\u00e1ndez","year":"2012","unstructured":"Fern\u00e1ndez, J. et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology 55, 1551\u20131561 (2012).","journal-title":"Hepatology"},{"key":"BFnm3516_CR6","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00134-012-2523-2","volume":"38","author":"AJ O'Brien","year":"2012","unstructured":"O'Brien, A.J., Welch, C.A., Singer, M. & Harrison, D.A. Prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients. Intensive Care Med. 38, 991\u20131000 (2012).","journal-title":"Intensive Care Med."},{"key":"BFnm3516_CR7","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1136\/bmj.282.6272.1262","volume":"282","author":"A Hassner","year":"1981","unstructured":"Hassner, A. et al. Impaired monocyte function in liver cirrhosis. Br. Med. J. (Clin. Res. Ed.) 282, 1262\u20131263 (1981).","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"BFnm3516_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/hep.1840060217","volume":"6","author":"IA Rajkovic","year":"1986","unstructured":"Rajkovic, I.A. & Williams, R. Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 6, 252\u2013262 (1986).","journal-title":"Hepatology"},{"key":"BFnm3516_CR9","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/hep.22474","volume":"48","author":"DL Shawcross","year":"2008","unstructured":"Shawcross, D.L. et al. Ammonia impairs neutrophil phagocytic function in liver disease. Hepatology 48, 1202\u20131212 (2008).","journal-title":"Hepatology"},{"key":"BFnm3516_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.dld.2013.07.015","volume":"46","author":"S Fagiuoli","year":"2014","unstructured":"Fagiuoli, S. et al. Management of infections in cirrhotic patients: report of a consensus conference. Dig. Liver Dis. 46, 204\u2013212 (2014).","journal-title":"Dig. Liver Dis."},{"key":"BFnm3516_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2310\/JIM.0b013e31819aaa76","volume":"57","author":"JU Scher","year":"2009","unstructured":"Scher, J.U. & Pillinger, M.H. The anti-inflammatory effects of prostaglandins. J. Investig. Med. 57, 703\u2013708 (2009).","journal-title":"J. Investig. Med."},{"key":"BFnm3516_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4049\/jimmunol.1101029","volume":"188","author":"P Kalinski","year":"2012","unstructured":"Kalinski, P. Regulation of immune responses by prostaglandin E2. J. Immunol. 188, 21\u201328 (2012).","journal-title":"J. Immunol."},{"key":"BFnm3516_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/path.4232","volume":"231","author":"JN Fullerton","year":"2013","unstructured":"Fullerton, J.N., O'Brien, A.J. & Gilroy, D.W. Pathways mediating resolution of inflammation: when enough is too much. J. Pathol. 231, 8\u201320 (2013).","journal-title":"J. Pathol."},{"key":"BFnm3516_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.it.2013.10.008","volume":"35","author":"JN Fullerton","year":"2014","unstructured":"Fullerton, J.N., O'Brien, A.J. & Gilroy, D.W. Lipid mediators in immune dysfunction after severe inflammation. Trends Immunol. 35, 12\u201321 (2014).","journal-title":"Trends Immunol."},{"key":"BFnm3516_CR15","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1165\/rcmb.2007-0153OC","volume":"37","author":"CH Serezani","year":"2007","unstructured":"Serezani, C.H. et al. Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase. Am. J. Respir. Cell Mol. Biol. 37, 562\u2013570 (2007).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"BFnm3516_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1189\/jlb.1211590","volume":"92","author":"E Bourdonnay","year":"2012","unstructured":"Bourdonnay, E., Serezani, C.H., Aronoff, D.M. & Peters-Golden, M. Regulation of alveolar macrophage p40phox: hierarchy of activating kinases and their inhibition by PGE2. J. Leukoc. Biol. 92, 219\u2013231 (2012).","journal-title":"J. Leukoc. Biol."},{"key":"BFnm3516_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.4049\/jimmunol.173.1.559","volume":"173","author":"DM Aronoff","year":"2004","unstructured":"Aronoff, D.M., Canetti, C. & Peters-Golden, M. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J. Immunol. 173, 559\u2013565 (2004).","journal-title":"J. Immunol."},{"key":"BFnm3516_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1084\/jem.20082058","volume":"206","author":"AI Medeiros","year":"2009","unstructured":"Medeiros, A.I., Serezani, C.H., Lee, S.P. & Peters-Golden, M. Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2\/EP2 signaling. J. Exp. Med. 206, 61\u201368 (2009).","journal-title":"J. Exp. Med."},{"key":"BFnm3516_CR19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1165\/rcmb.2011-0025RT","volume":"45","author":"PD Bozyk","year":"2011","unstructured":"Bozyk, P.D. & Moore, B.B. Prostaglandin E2 and the pathogenesis of pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 45, 445\u2013452 (2011).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"BFnm3516_CR20","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1110\/ps.28702","volume":"11","author":"J Yang","year":"2002","unstructured":"Yang, J., Petersen, C.E., Ha, C.E. & Bhagavan, N.V. Structural insights into human serum albumin-mediated prostaglandin catalysis. Protein Sci. 11, 538\u2013545 (2002).","journal-title":"Protein Sci."},{"key":"BFnm3516_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jhep.2004.10.019","volume":"42","author":"HE Wasmuth","year":"2005","unstructured":"Wasmuth, H.E. et al. Patients with acute on chronic liver failure display \u201csepsis-like\u201d immune paralysis. J. Hepatol. 42, 195\u2013201 (2005).","journal-title":"J. Hepatol."},{"key":"BFnm3516_CR22","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/00000658-199206000-00001","volume":"215","author":"JA Goss","year":"1992","unstructured":"Goss, J.A., Mangino, M.J. & Flye, M.W. Prostaglandin E2 production during hepatic regeneration downregulates Kupffer cell IL-6 production. Ann. Surg. 215, 553\u2013559, discussion 559\u2013560 (1992).","journal-title":"Ann. Surg."},{"key":"BFnm3516_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1042\/bj3210639","volume":"321","author":"RJ McAnulty","year":"1997","unstructured":"McAnulty, R.J., Hernandez-Rodriguez, N.A., Mutsaers, S.E., Coker, R.K. & Laurent, G.J. Indomethacin suppresses the anti-proliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures. Biochem. J. 321, 639\u2013643 (1997).","journal-title":"Biochem. J."},{"key":"BFnm3516_CR24","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/hep.26359","volume":"57","author":"BA Runyon","year":"2013","unstructured":"Runyon, B.A. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology 57, 1651\u20131653 (2013).","journal-title":"Hepatology"},{"issue":"suppl. 1","key":"BFnm3516_CR25","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/S1665-2681(19)31601-1","volume":"10","author":"A Alves de Mattos","year":"2011","unstructured":"Alves de Mattos, A. Current indications for the use of albumin in the treatment of cirrhosis. Ann. Hepatol. 10 (suppl. 1), S15\u2013S20 (2011).","journal-title":"Ann. Hepatol."},{"key":"BFnm3516_CR26","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/hep.21737","volume":"46","author":"RP Mookerjee","year":"2007","unstructured":"Mookerjee, R.P. et al. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology 46, 831\u2013840 (2007).","journal-title":"Hepatology"},{"key":"BFnm3516_CR27","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.26338","volume":"58","author":"R Garcia-Martinez","year":"2013","unstructured":"Garcia-Martinez, R. et al. Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology 58, 1836\u20131846 (2013).","journal-title":"Hepatology"},{"key":"BFnm3516_CR28","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3748\/wjg.v12.i9.1403","volume":"12","author":"RG Romanelli","year":"2006","unstructured":"Romanelli, R.G. et al. Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. World J. Gastroenterol. 12, 1403\u20131407 (2006).","journal-title":"World J. Gastroenterol."},{"key":"BFnm3516_CR29","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.6050","volume":"95","author":"P Georgiev","year":"2008","unstructured":"Georgiev, P. et al. Characterization of time-related changes after experimental bile duct ligation. Br. J. Surg. 95, 646\u2013656 (2008).","journal-title":"Br. J. Surg."},{"key":"BFnm3516_CR30","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jhep.2009.09.008","volume":"51","author":"M Domenicali","year":"2009","unstructured":"Domenicali, M. et al. A novel model of CCl4-induced cirrhosis with ascites in the mouse. J. Hepatol. 51, 991\u2013999 (2009).","journal-title":"J. Hepatol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.3516.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3516","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3516.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:45:13Z","timestamp":1684449913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,13]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["BFnm3516"],"URL":"https:\/\/doi.org\/10.1038\/nm.3516","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,13]]},"assertion":[{"value":"20 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}